DIH Holdings US Inc (DHAI) News

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with...

Form 8-K - Current report

AbbVie Reports Second-Quarter 2024 Financial Results

AbbVie Reports Second-Quarter 2024 Financial Results PR Newswire NORTH CHICAGO, Ill., July 25, 2024 Reports...

U.S. Index Futures Mixed After Tech Sell-Off, Oil Prices Drop on Weak China Demand and Ceasefire Expectations

U.S. index futures are mixed in pre-market trading on Thursday following a sharp tech sector sell-off the...

L'Agence des médicaments du Canada octroie à AbbVie sa toute première recommandation de remboursement à durée limitée pour EPKINLY (MC)

L'Agence des médicaments du Canada octroie à AbbVie sa toute première recommandation de...

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis PR...

AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer

AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer PR...

Tesla Listed for China’s Government Vehicles; Macy’s Acquisition Offer Raised, and More News

Tesla (NASDAQ:TSLA) – The Tesla Model Y was included for the first time on a list of plug-in electric...

AbbVie to Host Second-Quarter 2024 Earnings Conference Call

AbbVie to Host Second-Quarter 2024 Earnings Conference Call PR Newswire NORTH CHICAGO, Ill., July 2, 2024...

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer PR Newswire NORTH CHICAGO, Ill., July 1, 2024 As Previously Announced, Richard...

AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma

AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with...

AbbVie Acquires Celsius Therapeutics

AbbVie Acquires Celsius Therapeutics PR Newswire NORTH CHICAGO, Ill., June 27, 2024 Celsius' CEL383 is a...

Introducing Allē Payment Plans, Powered by Cherry

Introducing Allē Payment Plans, Powered by Cherry PR Newswire IRVINE, Calif., June 27, 2024 Allē Members Enjoy...

U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma

U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients...